Asunto(s)
Enfermedad Coronaria/etiología , Enfermedades del Prematuro/etiología , Nutrición Parenteral Total/efectos adversos , Catéteres de Permanencia/efectos adversos , Enfermedad Coronaria/diagnóstico , Enfermedad Coronaria/terapia , Ecocardiografía , Humanos , Enfermedad de la Membrana Hialina/terapia , Recién Nacido , MasculinoAsunto(s)
Colestasis/etiología , Puntaje de Apgar , Parto Obstétrico , Susceptibilidad a Enfermedades , Edad Gestacional , Humanos , Enfermedad de la Membrana Hialina/complicaciones , Hipotensión/complicaciones , Lactante , Recién Nacido de Bajo Peso , Recién Nacido , Nutrición Parenteral Total/efectos adversos , Estudios Prospectivos , Factores de TiempoAsunto(s)
Anemia de Células Falciformes/etiología , Reacción a la Transfusión , Acidosis/complicaciones , Anemia/complicaciones , Bancos de Sangre/normas , Humanos , Hipotensión/complicaciones , Recién Nacido , Ictericia Neonatal/complicaciones , Ictericia Neonatal/terapia , Masculino , Síndrome de Circulación Fetal Persistente/complicaciones , Respiración ArtificialRESUMEN
Mean aortic blood pressure volume were measured in true premature infants with respiratory distress syndrome. Seven infants had Type I RDS (hyaline membrane disease) and ten had transient tachypnea of the newborn (Type II RDS). Blood volume in the infants with Type I RDS was significantly lower than in the infants with Type II RDS. The difference was due to a low red cell volume. Mean aortic blood pressure was within the range of normal in all infants and therefore did not reflect the low blood volume of infants with Type I RDS. Normal mean aortic blood pressure does not indicate normal blood volume or normal circulation in infants with RDS.
Asunto(s)
Presión Sanguínea , Volumen Sanguíneo , Síndrome de Dificultad Respiratoria del Recién Nacido/fisiopatología , Aorta Abdominal , Peso al Nacer , Femenino , Edad Gestacional , Hematócrito , Humanos , Recién Nacido , MasculinoRESUMEN
Infants with IRDS were treated with CPAP early (0.40 FIO2; WITH PaO2 less than 60 mm Hg) or late (0.70 FIO2; with PaO2 less than 60 mm Hg). There was no difference in survival, duration of CPAP therapy, total time of oxygen administration, or complications. The early treated infants needed a lower FIO2 (maximum 0.55) and had a less severe clinical course. The late treated infants were subjected to 0.70 or more FIO2 for an average of 24 hours and were in greater than 0.40 FIO2 significantly longer than those given CPAP early. Infants who weighed less than 1,500 gm and had severe disease did not do well regardless of when CPAP was applied.